obinutuzumab

Ligand id: 6941

Name: obinutuzumab

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: obinutuzumab

Immunopharmacology Disease
Disease X-Refs Comment References
Chronic lymphocytic leukemia Disease Ontology: DOID:1040
OMIM: 151400
Orphanet: ORPHA67038
Approved for use in combination with chemotherapy in patients who have received no prior therapy.
Follicular lymphoma Disease Ontology: DOID:0050873
Approval is for a combination therapy of obinutuzumab with bendamustine, followed by obinutuzumab monotherapy.